BrainChip (BRN) Q4 2025 earnings summary

Executive summary

• Customer cash inflows reached US$0.4M, consistent with the prior quarter (US$0.3M).

• Payments to suppliers and employees decreased to US$4.3M from US$5.2M in the previous quarter.

• Cash balance increased to US$31.7M from US$13.9M in the prior quarter.

• Strategic partnership announced with Blue Ridge Envisioneering (Parsons) for deployment of Akida neuromorphic processors.

• Successful A$35M (US$22.8M) institutional placement and oversubscribed share purchase plan completed.

Financial highlights

• Net operating cash outflows improved to US$3.5M from US$4.9M in the prior quarter.

• Investment cash outflows of US$1.98M related to capitalised R&D for AKD1500 production.

• Cash inflows from financing activities totaled US$24.7M, with share issue costs of US$1.4M.

• Receipts from customers for the quarter were US$408K.

• Payments for R&D, manufacturing, marketing, and staff costs totaled US$4.3M.

Outlook and guidance

• Estimated quarters of funding available is 9.2, indicating strong liquidity for future operations.

• Volume production of AKD1500 scheduled for Q3'26, with ongoing customer engagements and orders.